A randomised controlled trial of L-arginine and-or vitamin D to improve outcomes in pulmonary tuberculosis

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/605806

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Two nutrients, arginine and vitamin D, are used by defence cells in our lungs to kill the tuberculosis bacteria. We will test whether giving arginine and-or vitamin D to people with TB (in addition to their usual TB medications) will help them recover faster and cause less long-term lung damage. We will also check whether these nutrients make them less infectious to other people.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2015

Funding Scheme: NHMRC Project Grants

Funding Amount: $942,297.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Infectious Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Arginine and nitric oxide | PGP3 | Randomised controlled trial | Respiratory diseases | Tropical medicine | Tuberculosis | Vitamin D

Related Links